Curanex Pharmaceuticals CURX
NASDAQ CURX
$5.01 +0.39 (+8.43%)
As of: Oct 21, 2026 · 2:44 PM EDT

Curanex Pharmaceuticals (CURX) Total Current Liabilities (2024 - 2026)

Updated

Curanex Pharmaceuticals (CURX) reported Total Current Liabilities of $104,306 for Q2 2026, up 37.4% from $75,927 a year earlier.

Analysis

Curanex Pharmaceuticals (CURX) Total Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Curanex Pharmaceuticals posted Total Current Liabilities of $137,030, up 840.2% from FY2024.

  • By year, Total Current Liabilities came in at $14,575 in FY2024.
  • Five-year quarterly Total Current Liabilities spans a low of $14,575 in Q4 2024 and a high of $185,955 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 54.90 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 41.64 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 31.55 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.02 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 32.65 Bn
10 Curanex Pharmaceuticals 7.11 Mn -6.75 Mn - 104,306.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 104,306.00
Dec 31, 2025 137,030.00
Sep 30, 2025 185,955.00
Jun 30, 2025 75,927.00
Dec 31, 2024 14,575.00
API Access

Curanex Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=CURX&period=max&api_key=YOUR_API_KEY